Pharmacodynamic efficacy of IONIS-FB-LRX, a complement factor B antisense oligonucleotide, in a phase 1 clinical study. (October 2018) - McCaleb, Michael; Hughes, Steve; Greary, Richard; Monia, Brett; Grossman, Tamar